Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 89 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: The NCIC clinical trials group and AGITG co.Siu, L.; Shapiro, J.; Jonker, D.; Karapetis, C.; Zalcberg, J.; Simes, J.; Couture, F.; Moore, M.; Price, T.; Siddiqui, J.; Nott, L.; Charpentier, D.; Liauw, W.; Sawyer, M.; Jefford, M.; Magoski, N.; Haydon, A.; Walters, I.; Ringash, J.; Tu, D.; et al.
2013Comparison of 2 weight-loss diets of different protein content on bone health: a randomized trialJesudason, D.; Nordin, B.; Keogh, J.; Clifton, P.
2013Endoscopic transethmoidal approach with or without medial rectus detachment for orbital apical cavernous hemangiomasWu, W.; Selva-Nayagam, D.; Jiang, F.; Jing, W.; Tu, Y.; Chen, B.; Shi, J.; Sun, M.; Qu, J.
2013Incidence of canalicular closure with endonasal dacryocystorhinostomy without intubation in primary nasolacrimal duct obstructionCannon, P.; Chan, W.; Selva-Nayagam, D.
2013Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean menHutchison, A.; Luscombe-Marsh, N.; Saies, A.; Little, T.; Standfield, S.; Horowitz, M.; Feinle-Bisset, C.
2013The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumorsRosen, L.; Lipton, L.; Price, T.; Belman, N.; Boccia, R.; Hurwitz, H.; Stephenson Jr, J.; Wirth, L.; McCoy, S.; Hei, Y.; Hsu, C.; Tebbutt, N.
2013Childhood maltreatment is associated with an automatic negative emotion processing bias in the amygdalaDannlowski, U.; Kugel, H.; Huber, F.; Stuhrmann, A.; Redlich, R.; Grotegerd, D.; Dohm, K.; Sehlmeyer, C.; Konrad, C.; Baune, B.; Arolt, V.; Heindel, W.; Zwitserlood, P.; Suslow, T.
2013Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progressionButler, M.; Ricciardelli, C.; Tilley, W.; Hickey, T.
2013Early molecular response and female sex strongly predict stable undetectable BCR-ABL1, the criteria for imatinib discontinuation in patients with CMLBranford, S.; Yeung, D.; Ross, D.; Prime, J.; Field, C.; Altamura, H.; Yeoman, A.; Georgievski, J.; Jamison, B.; Phillis, S.; Sullivan, B.; Briggs, N.; Hertzberg, M.; Seymour, J.; Reynolds, J.; Hughes, T.
2013GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutationsPerugini, M.; Iarossi, D.; Kok, C.; Cummings, N.; Diakiw, S.; Brown, A.; Danner, S.; Bardy, P.; To, L.; Wei, A.; Lewis, I.; D'Andrea, R.